Middle East & Africa Colorectal Cancer Diagnostics Market to 2032
Overview
The Middle East & Africa Colorectal Cancer Diagnostics Market is expected to reach a 276.84 USD Million by 2032 and is projected to grow at a CAGR of 9.92% from 2025 to 2032.
Revenue, 2024 (USD Million)
162.70
Forecast, 2032 (USD Million)
276.84
CAGR, 2024 - 2032
9.92%
Report Coverage
Middle East & Africa
Middle East & Africa Colorectal Cancer Diagnostics Market 2018-2032 USD Million
Middle East & Africa Colorectal Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 162.70 USD Million
- Projected Market Size (2032): 276.84 USD Million
- CAGR (2025-2032): 9.92%
Key Findings of Middle East & Africa Colorectal Cancer Diagnostics Market
- The Middle East & Africa Colorectal Cancer Diagnostics Market was valued at 162.70 USD Million in 2024.
- The Middle East & Africa Colorectal Cancer Diagnostics Market is likely to grow at a CAGR of 9.92% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Instruments in Product Type Segment accounted for the largest share of the market with a revenue of 119.51 USD Million
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 12.59% during the forecast period from 2024 to 2032.
Middle East & Africa Colorectal Cancer Diagnostics Market Scope
Middle East & Africa Colorectal Cancer Diagnostics Market Segmentation & Scope
Test Type
- Others
- Biopsy
- Tumor Markers
- Imaging Test
- Blood Test
- Stool Examination
Cancer Stages
- Stage 0
- Stage I
- Stage II
- Stage IV
- Stage III
Cancer Type
- Others
- Carcinoid Tumors
- Gastrointestinal Stromal Tumors
- Colorectal Lymphoma
- Adenocarcinoma
Age Group
- Pediatric
- Adults
- Geriatric
End User
- Others
- Academic Institutes
- Ambulatory Surgical Centers
- Cancer Research Centers
- Diagnostic Centers
- Hospitals
Product Type
- Consumables & Accessories
- Instruments
Middle East & Africa Colorectal Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 162.70 USD Million |
| Market Value in 2032 | 276.84 USD Million |
| CAGR (2025-2032) | 9.92% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Test Type,Cancer Stages,Cancer Type,Age Group,End User,Product Type |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 162.70 USD Million in 2024
- Key Country: South Africa, leading in terms of revenue with value of 62.26 USD Million in 2024.
Segments and Scope
-
Middle East & Africa Colorectal Cancer Diagnostics Market to 2032, By Test Type
- Stool Examination is the largest segment in Middle East & Africa Colorectal Cancer Diagnostics Market to 2032 with a revenue of 75.16 USD Million in the year 2024.
- Stool Examination is the Fastest growing segment in Middle East & Africa Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 11.74 % in forecast period 2025-2032.
-
Middle East & Africa Colorectal Cancer Diagnostics Market to 2032, By Cancer Stages
- Stage III is the largest segment in Middle East & Africa Colorectal Cancer Diagnostics Market to 2032 with a revenue of 77.61 USD Million in the year 2024.
- Stage III is the Fastest growing segment in Middle East & Africa Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 11.89 % in forecast period 2025-2032.
-
Middle East & Africa Colorectal Cancer Diagnostics Market to 2032, By Cancer Type
- Adenocarcinoma is the largest segment in Middle East & Africa Colorectal Cancer Diagnostics Market to 2032 with a revenue of 106.45 USD Million in the year 2024.
- Adenocarcinoma is the Fastest growing segment in Middle East & Africa Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 10.64 % in forecast period 2025-2032.
-
Middle East & Africa Colorectal Cancer Diagnostics Market to 2032, By Age Group
- Geriatric is the largest segment in Middle East & Africa Colorectal Cancer Diagnostics Market to 2032 with a revenue of 85.45 USD Million in the year 2024.
- Geriatric is the Fastest growing segment in Middle East & Africa Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 10.74 % in forecast period 2025-2032.
-
Middle East & Africa Colorectal Cancer Diagnostics Market to 2032, By End User
- Hospitals is the largest segment in Middle East & Africa Colorectal Cancer Diagnostics Market to 2032 with a revenue of 59.12 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Middle East & Africa Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 12.59 % in forecast period 2025-2032.
-
Middle East & Africa Colorectal Cancer Diagnostics Market to 2032, By Product Type
- Instruments is the largest segment in Middle East & Africa Colorectal Cancer Diagnostics Market to 2032 with a revenue of 119.51 USD Million in the year 2024.
- Instruments is the Fastest growing segment in Middle East & Africa Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 10.95 % in forecast period 2025-2032.
Middle East & Africa Colorectal Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Illumina, Inc. | |||
| Koninklijke Philips N.V. | |||
| Thermo Fisher Scientific Inc. | |||
| Quest Diagnostics Incorporated | |||
| Bio-Rad Laboratories, Inc. | |||
Middle East & Africa Colorectal Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million
Middle East & Africa Colorectal Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Middle East & Africa Colorectal Cancer Diagnostics Market is segmented based on Segmentation Test Type,Cancer Stages,Cancer Type,Age Group,End User,Product Type.
Middle East & Africa Colorectal Cancer Diagnostics Market was valued at USD 162.70(Revenue in USD Million) in 2021.
Middle East & Africa Colorectal Cancer Diagnostics Market is projected to grow at a CAGR of 9.92% during the forecast period of 2024 to 2032.
The Instruments segment is expected to dominate the Middle East & Africa Colorectal Cancer Diagnostics Market, holding a largest market share of 119.51 USD Million in 2024
Middle East & Africa Colorectal Cancer Diagnostics Market Scope
Middle East & Africa Colorectal Cancer Diagnostics Market Segmentation & Scope
Test Type
- Others
- Biopsy
- Tumor Markers
- Imaging Test
- Blood Test
- Stool Examination
Cancer Stages
- Stage 0
- Stage I
- Stage II
- Stage IV
- Stage III
Cancer Type
- Others
- Carcinoid Tumors
- Gastrointestinal Stromal Tumors
- Colorectal Lymphoma
- Adenocarcinoma
Age Group
- Pediatric
- Adults
- Geriatric
End User
- Others
- Academic Institutes
- Ambulatory Surgical Centers
- Cancer Research Centers
- Diagnostic Centers
- Hospitals
Product Type
- Consumables & Accessories
- Instruments
Frequently Asked Questions
The Middle East & Africa Colorectal Cancer Diagnostics Market is segmented based on Segmentation Test Type,Cancer Stages,Cancer Type,Age Group,End User,Product Type.
Middle East & Africa Colorectal Cancer Diagnostics Market was valued at USD 162.70(Revenue in USD Million) in 2021.
Middle East & Africa Colorectal Cancer Diagnostics Market is projected to grow at a CAGR of 9.92% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Colorectal Cancer Diagnostics Market for final year is USD 276.84 (USD Million).
Middle East & Africa Colorectal Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Colorectal Cancer Diagnostics Market is segmented based on Segmentation Test Type,Cancer Stages,Cancer Type,Age Group,End User,Product Type.
Middle East & Africa Colorectal Cancer Diagnostics Market was valued at USD 162.70(Revenue in USD Million) in 2021.
Middle East & Africa Colorectal Cancer Diagnostics Market is projected to grow at a CAGR of 9.92% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Colorectal Cancer Diagnostics Market for final year is USD 276.84 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.